Sunday, May 3, 2015
- 5:30pm-6:30pm
-
Mesenchymal Stem Cell Therapy to Improve Functional Outcome in Vascular Composite Allotransplantation (VCA)
- 5:30pm-6:30pm
-
Mesenchymal Stem Cells Prevent Cold Ischemia-Reperfusion Injury in Lung Transplants
Poster Session B: Cell Transplantation and Cell Therapies • Exhibit Hall E
- 5:30pm-6:30pm
-
Mesenchymal Stem Cells Suppress Cytotoxicity of Activated Natural Killer Cells in Liver Via the TRAIL-TRAIL Receptor Pathway in Islet Transplantation
Poster Session B: Cell Transplantation and Cell Therapies • Exhibit Hall E
- 5:30pm-6:30pm
-
Mesenchymal Stromal Cells (MSCs) Given Post-Transplant Together With C3a and C5a Receptor Antagonists Prevent Engraftment Syndrome and Induce a Mild Not-Significant Prolongation of Graft Survival
Poster Session B: Cell Transplantation and Cell Therapies • Exhibit Hall E
- 5:30pm-6:30pm
-
Microvascular (MIA) and Interstitial (i) Inflammation Influence Late Death-Censored Graft Failure (DCGF) After Kidney Transplantation
Poster Session B: Kidney Complications: Late Graft Failure • Exhibit Hall E
- 5:30pm-6:30pm
-
MiR-26a Regulates Mouse Hepatocyte Proliferation By Directly Targeting Their 3′ Untranslated Region of CCNE2/CCND2
Poster Session B: Cell Transplantation and Cell Therapies • Exhibit Hall E
- 5:30pm-6:30pm
-
Mitochondrial Feedback Mechanisms in Kidney Cell Senescence
Poster Session B: Kidney Complications: Late Graft Failure • Exhibit Hall E
- 5:30pm-6:30pm
-
Moderate Rejection Episode of Face Transplant After mTOR Conversion to Preserve Renal Function
- «Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 46
- Next Page»